Anti-TCR Vδ3 Antibody, anti-human, REAfinity™
Synonyms: TCRVdelta3, TCRVd3, TCR Vdelta3, TCR V delta 3
RECOMBINANT EXTENDED VALIDATION
Clone:
REA1426 | P11.5B
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC Glossary
External link icon
Select a conjugate:
Select a size:
Other sizes

Related products for Anti-TCR Vδ3 Antibody, anti-human, REAfinity™

Flow cytometry applications
APC
PE
PE-Vio 670
Vio Bright V423
Species tested:
human
Recommended dilution:
1:50
Remark:
Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-139-026, 130-138-971
Description:
Mobilized leukapheresis cells were stained with Anti-TCR Vδ3 antibodies or with the corresponding REA Control (S) antibodies (left image). Cells were analyzed by flow cytometry using the MACSQuant® Analyzer. CD3+ / TCR Vδ1-/ TCR Vδ2- / TCRab- cells were pregated for the analysis. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence or 4',6-diamidino-2-phenylindole (DAPI) fluorescence, as in the case of tandem conjugates.

Application imageView details view details

Application imageView details view details
Extended validation for Anti-TCR Vδ3 Antibody, anti-human, REAfinity™
Sensitivity
Fixation data

To provide an indication on how an antibody performs after fixation of cells, in-house data on staining results before and after fixation with 3.7% formaldehyde using Miltenyi Biotec antibodies are provided. Different experimental settings may lead to different results.

No fixation
Extended-Validation detailed information image
Post fixation
Extended-Validation detailed information image

Comparison of staining pattern on non-fixed and fixed cells using TCR Vδ3 (REA1426). The performance of the antibody after fixation was tested by comparing the staining pattern on fresh (no fixation) versus fixed (post fixation) cells.

Specifications for Anti-TCR Vδ3 Antibody, anti-human, REAfinity™
Overview

Clone REA1426 recognizes Vδ3 chain of the human γδ T cell receptor (TCR).Gamma-delta TRs recognize a variety of self and foreign non-peptide antigens frequently expressed at the epithelial boundaries between the host and external environment. Upon antigen recognition induces rapid, innate-like immune responses involved in pathogen clearance and tissue repair.

Additional information: Clone REA1426 displays negligible binding to Fc receptors.

Alternative names

TCRVdelta3, TCRVd3, TCR Vdelta3, TCR V delta 3

Detailed product information

Technical specifications

Clone
REA1426
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (S), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
TCR Vδ3
Distribution of antigen
T cells

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for Anti-TCR Vδ3 Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support